On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

Cell and gene therapies (CGT) continue to advance in the pharmaceutical industry. Despite continued investment in R&D, the ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Join us for a landmark discussion celebrating the remarkable journey of the biotechnology industry, from its foundational moments to the groundbreaking innovations of today. As we mark the 50th ...

Sana Biotechnology (SANA) is back in focus after Mayo Clinic agreed to collaborate on SC451 for type 1 diabetes and invest up to US$50 million, linking clinical expertise with fresh capital support.

Grogan served as assistant to President Trump and director of the Domestic Policy Council 2019-2020. On April 15, President Trump issued an awaited executive order on drug pricing, kicking off a new ...

John F. Crowley is president and CEO of the Biotechnology Innovation Organization. Kendalle Burlin O’Connell is CEO and president of MassBio. As nearly 20,000 scientists, executives, investors, ...

Launched on January 31, 2006, the State Street SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the ...

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.